FDA drug recalls

This hub indexes recent United States Food and Drug Administration (FDA) drug recall enforcement reports. It is a finding aid for locating and dating official recall records — it is regulatory information only, and it is not medical advice.

250 Recalls indexed
219 Class II
2026-06-13 Last updated

What a drug recall is, in regulatory terms

A recall is the principal mechanism by which a problem discovered after a drug reaches the market is formally addressed. When a firm, sometimes at the FDA's request, decides to remove or correct a marketed product, the action is logged by the agency as an enforcement report. That report captures the product description, the recalling firm, the reason the firm gave for the recall, the distribution pattern, the geographic scope, and a set of dates marking when the recall was initiated, reported and — if applicable — terminated. Recalls are routine and frequent; they are a sign that the post-market surveillance system is doing its job, not, in themselves, a verdict on a company.

Recalls can be initiated for a wide range of regulatory reasons — for example, a labelling discrepancy, a manufacturing deviation, a packaging defect, a stability question, or a contamination concern. The enforcement report records the firm's stated reason as a data field. On this site that reason is reproduced verbatim as a regulatory data point so you can locate and verify it; it is never reframed as advice, and it should not be read as a clinical instruction. The authoritative record is always the FDA's, and every entry here links straight back to it. For the precise definitions of every field and tier referenced on this hub, see the regulatory intelligence glossary, and for the data lineage behind each record see the methodology and FDA data sources pages.

Recall classification: Class I, Class II and Class III

The FDA assigns each recall a classification that expresses the agency's regulatory assessment of the recall event. These tiers are defined by the FDA and are used consistently across its enforcement reporting:

It is important to be precise about what these labels are and are not. They are the FDA's classification of the recall event within its own regulatory framework. They are not a score of how dangerous a product is to any specific person, and they cannot be translated into personal risk. This site uses the classifications strictly as the agency's administrative severity tiers, which is exactly how the source data presents them. Across the indexed dataset there are currently 9 Class I, 219 Class II, 22 Class III and 0 unclassified recall entries.

Recall status

Alongside classification, each enforcement report carries a status describing where the recall sits in its lifecycle. In the indexed data, statuses currently break down as 250 ongoing, 0 completed, 0 terminated and 0 pending (with 0 where the source does not state a status). A status of "terminated" means the FDA has recorded the recall as concluded; an "ongoing" status means the action was still in progress at the time of the report. As with everything on this site, the status is a regulatory data field, and the live value should be confirmed against the official source.

Latest recalls

The most recent enforcement reports in the indexed dataset are listed below, newest first. Each links to its own record page and, from there, to the verifiable openFDA source.

RecordTypeDate
Nicotine Transdermal System Patch, 14 mg, 14 patches per box, Aveva, Distributed by: RUGBY LABORATORIES, Indianapolis, IN 46268, www.majorpharmaceuticals.com, NDC 0536-5895-88.Class III2026-06-03
PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.Class III2026-06-03
Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by: Safecor, Columbus, OH 43204. NDC: 64380-474-01Class II2026-05-27
fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.Class II2026-05-27
Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; (NDC 70710-1048-3).Class II2026-05-27
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur 441108, INDIA, a) 2 Pens- NDC 70748-346-02; b) 3 Pens - NDC 70748-346-03.Class II2026-05-27
Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; a) 30 count bottles (NDC 70710-1047-3); b) 100 count bottles (NDC 70710-1047-1).Class II2026-05-27
Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC: 68084-202-01; Individual Dose NDC: 68084-202-11Class III2026-05-27
Primidone Tablets, USP, 50 mg, 50-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC 51407-637-05Class III2026-05-27
Primidone Tablets, USP, 250 mg, 100-count bottle, RX only, Manufactured by: Lannett Company, Inc., Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC 51407-638-01Class III2026-05-27
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.Class I2026-05-27
cimzia (certolizumab pegol), 2x200mg/mL PREFILLED SYRINGES (2 single-dose), Rx ONLY, Manufactured by: UCB Inc., Smyrna, GA 30080, a) NDC 50474-710-79, b) Professional sample, NDC 50474-710-80; c) 3 cartons, STARTER KIT, NDC 50474-710-81.Class II2026-05-27
Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC: 68084-203-01; Individual Dose NDC: 68084-203-11Class III2026-05-27
Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20Class II2026-05-27
Busulfan Injection, 60 mg per 10 mL (6 mg per mL), 8x10 mL Single-Dose Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, Made in Canada, NDC 25021-241-10.Class III2026-05-27
Primidone Tablets USP, 250mg, 100-count bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-1231-01.Class III2026-05-27
Gas-X, Simethicone 125 mg/ ANTIGAS, 120 SoftGels, Distributed by: Haleon, Warren, NJ 07059, UPC: 3 00674 35041 9.Class II2026-05-27
Vitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid, Contains: Folic Acid 799 mcg/5mL, Delivers 5 mL per oral syringe, (Nephronex), Mfg By: LLORENS; Pkg by: Safecor, Columbus, OH. NDC 54859-0516-08Class II2026-05-27
Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Manufactured for: OASIS Medical, Inc., 514 S. Vermont Ave., Glendora, CA 91741, USA, Made in France, NDC 42126-6400-1.Class II2026-05-20
Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.Class II2026-05-20
Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.Class II2026-05-20
TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670Class II2026-05-13
BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Sterile Solution, 0.36 fl. oz. (10.5 mL) x 25 applicators per box. Carefusion 213, LLC, El Paso, TX 79912, subsidary of Becton Dickinson and Co. NDC 54365-014-41Class II2026-05-13
BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Sterile Solution, 25x26mL Applicators per carton. Carefusion 213 LLC, El Paso, TX 79912, NDC 54365-014-42.Class II2026-05-13
Duloxetine Delayed-Release Capsules, 30 mg, Rx Only, a) 90 Capsules, NDC 27241-098-09, b) 30 capsules, NDC 27241-098-03, c) 1000 Capsules, NDC 27241-098-10, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in IndiaClass II2026-05-13

Source & provenance

Official source
https://open.fda.gov/apis/drug/enforcement/
Source dataset
openFDA Drug Enforcement API
Publication date
Not available
Ingested
2026-06-13

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.

Frequently asked questions

What is an FDA drug recall?

A drug recall is a regulatory action in which a firm removes or corrects a marketed product in cooperation with the FDA. The FDA records the action in its enforcement reports. A recall is an administrative action, not a clinical instruction to any individual.

What do Class I, Class II and Class III mean?

They are the FDA's regulatory severity tiers for a recall event. Class I denotes the most serious regulatory category, Class II an intermediate category, and Class III the least serious. These are administrative classifications of the recall event, not personalised risk statements.

Where does this recall data come from?

From the openFDA Drug Enforcement API, which exposes the FDA's enforcement reports in machine-readable form. Each record on this site links back to a verifiable openFDA query for the original report.

Does a recall mean a product is dangerous to me?

No. A recall record is an administrative fact about a regulatory action. It does not assess risk for any individual and is not medical advice. For any health question, consult a qualified healthcare professional and verify the record against the official FDA source.